EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Expression of ARMCX1 in Gastric Cancer Contributes to Prognosis and Influences Chemotherapy

Changheng Lv iD, Di Yang, Donghu Zhang iD, Jiajia Shen, Zechen Wang iD, Siyuan He, Lingzhang Meng iD, Jian Song iD, Jingjie Zhao iD

Journal of Immunology Research · 2023

DOI: 10.1155/2023/2623317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Immunology Research, 2023. Verfasst von Changheng Lv und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Systemic Inflammation Research (CSIR), School of Preclinical Medicine, Youjiang Medical University for Nationalities, Baise, Guangxi Provi…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Armadillo Domain Proteins, Oncogene Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Youjiang Medical University for Nationalities Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The altered expression of ARMCX1 in patients with gastric cancer has been reported frequently, yet its correlation to prognosis and chemotherapy needs to be unveiled. In combination of the gene expression data retrieved from TCGA database and bioinformatic analysis, this study discovered 590 differentially expressed genes in the cancerous biopsies isolated from gastric patients, compared with controls. Among which, ARMCX1 exhibited great potential to serve as a prognostic biomarker for gastric patients; furthermore, patients with low expression of ARMCX1 could be more sensitive to these 9 chemotherapeutic agents: A-770041, AMG-706, ATRA, BEZ235, bortezomib, CGP60474, dasatinib, HG-64-1, and pazopanib, rather than the other chemotherapeutic agents. This study helps the improvement of evaluating the prognosis of gastric cancer patients, and would help optimize chemotherapeutic strategies in consideration of the expression of ARMCX1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsArmadillo Domain ProteinsOncogene ProteinsHumansBiomarkers, TumorBortezomibPrognosis

Substanzen

Biomarkers, TumorBortezomibARMCX1 protein, humanArmadillo Domain ProteinsOncogene Proteins

Autor:innen und Institutionen

  • Center for Systemic Inflammation Research (CSIR), School of Preclinical Medicine, Youjiang Medical University for Nationalities, Baise, Guangxi Province, China.
  • Department of Pediatric Surgery, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi Province, China.
  • Institute of Cardiovascular Sciences, Guangxi Academy of Medical Sciences, Nanning, Guangxi Province, China.
  • Life Science and Clinical Research Center, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi Province, China.

ORCID-Profile: Changheng Lv, Donghu Zhang, Zechen Wang, Lingzhang Meng, Jian Song, Jingjie Zhao

Förderung

  • Youjiang Medical University for Nationalities Research Project

Zitieren

APA

Lv, C., Yang, D., Zhang, D., Shen, J., Wang, Z., He, S., Meng, L., Song, J., & Zhao, J. (2023). The Expression of ARMCX1 in Gastric Cancer Contributes to Prognosis and Influences Chemotherapy. Journal of Immunology Research. https://doi.org/10.1155/2023/2623317

Vancouver

Lv C, Yang D, Zhang D, Shen J, Wang Z, He S, et al. The Expression of ARMCX1 in Gastric Cancer Contributes to Prognosis and Influences Chemotherapy. Journal of Immunology Research. 2023. doi:10.1155/2023/2623317

BibTeX
@article{Lv2023,
  author = {Lv, Changheng and Yang, Di and Zhang, Donghu and Shen, Jiajia and Wang, Zechen and He, Siyuan and Meng, Lingzhang and Song, Jian and Zhao, Jingjie},
  title = {The Expression of ARMCX1 in Gastric Cancer Contributes to Prognosis and Influences Chemotherapy},
  journal = {Journal of Immunology Research},
  year = {2023},
  doi = {10.1155/2023/2623317}
}
Kostenlos starten →